Aetna (NYSE:AET) was upgraded by equities research analysts at Deutsche Bank from a “hold” rating to a “buy” rating in a report issued on Monday.

Several other analysts also recently issued reports on AET. Zacks Investment Research downgraded shares of Aetna from a “buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $175.00 price target on shares of Aetna in a research note on Monday, October 23rd. Citigroup upped their price target on shares of Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a research note on Thursday, November 2nd. Piper Jaffray Companies raised shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target on the stock in a research note on Wednesday, January 3rd. Finally, Jefferies Group upped their price target on shares of Aetna from $165.00 to $185.00 and gave the stock a “hold” rating in a research note on Wednesday, November 1st. Eleven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $172.64.

Shares of Aetna (NYSE AET) opened at $187.80 on Monday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53. Aetna has a one year low of $116.04 and a one year high of $192.37. The stock has a market cap of $61,255.16, a price-to-earnings ratio of 34.78, a price-to-earnings-growth ratio of 1.59 and a beta of 0.61.

Aetna (NYSE:AET) last announced its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The company had revenue of $14.99 billion for the quarter, compared to the consensus estimate of $15.12 billion. During the same period in the previous year, the business earned $2.07 EPS. The company’s revenue was down 5.0% on a year-over-year basis. equities research analysts anticipate that Aetna will post 9.78 earnings per share for the current year.

A number of institutional investors have recently bought and sold shares of the business. GSA Capital Partners LLP bought a new stake in Aetna during the second quarter valued at about $350,000. D.A. Davidson & CO. boosted its holdings in Aetna by 3.2% during the second quarter. D.A. Davidson & CO. now owns 7,341 shares of the company’s stock valued at $1,114,000 after acquiring an additional 225 shares during the period. FIL Ltd bought a new stake in Aetna during the second quarter valued at about $8,646,000. Advisor Group Inc. boosted its holdings in Aetna by 23.2% during the second quarter. Advisor Group Inc. now owns 16,292 shares of the company’s stock valued at $2,453,000 after acquiring an additional 3,073 shares during the period. Finally, Veritable L.P. boosted its holdings in Aetna by 0.9% during the second quarter. Veritable L.P. now owns 10,763 shares of the company’s stock valued at $1,634,000 after acquiring an additional 94 shares during the period. 87.88% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Aetna (AET) Lifted to “Buy” at Deutsche Bank” was posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.dailypolitical.com/2018/01/22/aetna-aet-lifted-to-buy-at-deutsche-bank.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.